GARCÍA MONDRAGÓN, MARIA LOURDES,GÓMORA PACHECO, MARISOL JUANA,RODRÍGUEZ BERNAL, PATRICIA MARÍA
申请号：
EP13860230
公开号：
EP2926813A4
申请日:
2013.11.01
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
This invention provides a combination of a hypoglycemic, metformin, and an irreversible intestinal gastric and pancreatic lipase inhibitor, Orlistat, for a better control of obesity than with the monotherapy used with each of them this composition provides "low" doses of both drugs to minimize secondary effects and to make use of the synergic effect of both compounds.
